NCT03138434

Brief Summary

This study aims to determine whether advanced MRI sequences can provide robust and clinically relevant information about abdominal aortic aneurysms (AAAs). The MRI sequences will study outcomes related to blood flow inside AAA, microvasculature of the AAA vessel wall and intraluminal thrombus inside AAA. Robustness of these MRI sequences will be determined with testing of feasibility and reproducibility. Clinical relevance will be assessed by studying the association between the primary outcomes and disease severity. Disease severity will be expressed by AAA diameter. It is our hypothesis that these parameters are significantly related to disease severity and may therefore be future markers of disease progression.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2017

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

May 1, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 3, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 29, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 29, 2019

Completed
Last Updated

July 5, 2019

Status Verified

July 1, 2019

Enrollment Period

2.1 years

First QC Date

May 1, 2017

Last Update Submit

July 2, 2019

Conditions

Keywords

Abdominal Aortic Aneurysm4D flow MRIDCE-MRIT1 and T2 mapping

Outcome Measures

Primary Outcomes (4)

  • Wall shear stress (WSS)

    Primary outcome of 4D flow MRI

    Time of MRI scan

  • Kinetic transport constant (Ktrans)

    Primary outcome of DCE-MRI

    Time of MRI scan

  • T1 relaxation time

    Primary outcome of T1 mapping

    Time of MRI scan

  • T2 relaxation time

    Primary outcome of T2 mapping

    Time of MRI scan

Secondary Outcomes (11)

  • Peak flow velocity inside the aneurysm

    Time of MRI scan

  • Location of peak wall shear stress

    Time of MRI scan

  • Flow velocity at aneurysm entrance

    Time of MRI scan

  • Flow patterns

    Time of MRI scan

  • Oscillatory shear index

    Time of MRI scan

  • +6 more secondary outcomes

Study Arms (2)

Optimization phase

The first five patients will be included for the optimization of the MRI sequences. This is to ensure that a standard protocol will work for different sizes of AAA. These patients will only be scanned once.

Study phase

This phase will commence after the optimization phase. This phase is where we want to assess the feasibility, reproducibility and association with disease severity between MRI parameters and AAA. These twenty patients will be scanned twice, with an interval of 1 week ± 5 days. The study will be completed when we have 20 patients with 2 scans for each sequence, or when a maximum number of 30 patients in the study phase have been scanned.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients with an abdominal aortic aneurysms who are patients at the department of vascular surgery of the Academic Medical Center.

You may qualify if:

  • Adult patients (≥ 18 years of age)
  • Abdominal aortic aneurysm with a maximal aneurysm diameter of at least 30 mm

You may not qualify if:

  • Contra-indications for MRI
  • Severely reduced renal function (eGFR \< 30)
  • Previous allergic reaction to intravenous contrast agents
  • Suprarenal AAA
  • Pararenal AAA
  • Previous aneurysm repair
  • Inflammatory aneurysm
  • Mycotic or other infectious aneurysm
  • Vasculitis
  • Connective tissue disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Vascular Surgery

Amsterdam, Netherlands

Location

MeSH Terms

Conditions

Aortic Aneurysm, Abdominal

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Study Officials

  • Ron Balm, MD PhD

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
prof. dr.

Study Record Dates

First Submitted

May 1, 2017

First Posted

May 3, 2017

Study Start

April 12, 2017

Primary Completion

May 29, 2019

Study Completion

May 29, 2019

Last Updated

July 5, 2019

Record last verified: 2019-07

Locations